| Identification of individuals at high risk of developing rheumatoid arthritis : a balanced random forest model in a cohort of 1544 first-degree relatives | RMD open |  | | 2025 | 21 | 76 |
|
| Anti-Apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox inrheumatoid arthritis | ESC (Europan Society of Cardiology) Congress 2024 | | | 2024 | 9 | 0 |
|
| Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis | RMD open | | | 2024 | 112 | 93 |
|
| Anti-apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox in rheumatoid arthritis | 92nd EAS (European Atherosclerosis Society) Congress | | | 2024 | 14 | 0 |
|
| Anti-apolipoprotein A-1 IgG, incident cardiovascular events, and lipid paradox in rheumatoid arthritis | Frontiers in cardiovascular medicine | | | 2024 | 123 | 266 |
|
| Brief report: can COVID-19 infection trigger rheumatoid arthritis-associated autoimmunity in individuals at risk for the disease? A nested cohort study | Frontiers in medicine | | | 2023 | 71 | 114 |
|
| A potential role for chlamydial infection in rheumatoid arthritis development | Rheumatology | | | 2023 | 95 | 253 |
|
| Brief report : assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis | Frontiers in immunology | | | 2023 | 198 | 348 |
|
| Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases | Frontiers in immunology | | | 2023 | 135 | 99 |
|
| Peut-on prédire la polyarthrite rhumatoïde ? | Revue du rhumatisme monographies |  | | 2022 | 122 | 0 |
|
| Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling | Arthritis & rheumatology | | | 2022 | 137 | 168 |
|
| Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA on the severity of rheumatoid arthritis | Rheumatology | | | 2021 | 382 | 549 |
|
| Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis | BMJ Open | | | 2021 | 360 | 233 |
|
| Identification of biological pathways specific to phases preceding rheumatoid arthritis development through gene expression profiling | International Journal of Immunogenetics | | | 2021 | 219 | 0 |
|
| Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis | Arthritis Research and Therapy | | | 2020 | 418 | 596 |
|
| Measuring ACPA in the general population or primary care: is it useful? | RMD Open | | | 2020 | 244 | 227 |
|
| Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease | Rheumatology | | | 2020 | 335 | 9 |
|
| Prevotella copri in individuals at risk for rheumatoid arthritis | Annals of the Rheumatic Diseases | | | 2019 | 472 | 0 |
|
| Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance | Frontiers in Immunology | | | 2018 | 435 | 385 |
|
| Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis | Rheumatology | | | 2017 | 562 | 5 |
|
| The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis | Clinical Rheumatology | | | 2017 | 636 | 3 |
|
| Immune-mediated experimental arthritis in IL-33 deficient mice | Cytokine | | | 2014 | 680 | 0 |
|
| The severity of experimental arthritis is independent of IL-36 receptor signaling | Arthritis research & therapy | | | 2013 | 636 | 356 |
|
| Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions | Journal of leukocyte biology | | | 2013 | 553 | 585 |
|
| Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency | Arthritis research & therapy | | | 2013 | 651 | 311 |
|
| Endogenous IL-1α is a chromatin-associated protein in mouse macrophages | Cytokine | | | 2013 | 646 | 1 |
|
| Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments | Arthritis and rheumatism | | | 2012 | 629 | 1 |
|
| Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis | European Journal of Immunology | | | 2012 | 629 | 3 |
|
| The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters | Journal of leukocyte biology |  | | 2012 | 718 | 0 |
|
| IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells | Blood | | | 2012 | 889 | 1,094 |
|
| Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice | Annals of the rheumatic diseases | | | 2012 | 683 | 0 |
|
| IL-36R ligands are potent regulators of dendritic and T cells | Blood | | | 2011 | 665 | 0 |
|
| Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis | Arthritis and rheumatism | | | 2011 | 653 | 0 |
|
| Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice | The Journal of immunology | | | 2010 | 571 | 0 |
|
| Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist | Arthritis and rheumatism | | | 2010 | 626 | 0 |
|
| IL-1 pathways in inflammation and human diseases | Nature reviews. Rheumatology | | | 2010 | 750 | 1 |
|
| Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis | Arthritis and rheumatism | | | 2009 | 663 | 0 |
|
| Production and functional role of Interleukin-1 receptor antagonist in immune and inflammatory responses in vivo | | | | 2009 | 1,184 | 1,123 |
|
| Interleukin-33 is biologically active independently of caspase-1 cleavage | The Journal of biological chemistry | | | 2009 | 690 | 560 |
|
